KNTE
Kinnate Biopharma Inc.
Director Carl L Gordon bought $2.0M of Kinnate Biopharma Inc.
Bought$1,989,446
$10.17Price
195,700Shares
+5%Stake
What KNTE did for a copier
- $1,000 copied at Wed, Feb 16 open, $10.46
- $1,076
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Mar 31 close.
Carl L Gordon's record
14 other buys with 3 months of prices since 2016: on average −7.4% against the S&P 500, and 6 of 14 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Feb 11. Filed Tue, Feb 15, 4:51 PM ET, after the close. Returns use the Feb 16 open and the Mar 31 close. Not investment advice.